Heparin interactions. Heparin: Uses, Dosage, Side Effects, and Critical Interactions
What are the primary uses of heparin. How is heparin dosage determined. What are the most common side effects of heparin. Which drugs have major interactions with heparin. How does heparin affect patients with certain medical conditions.
Understanding Heparin: An Essential Anticoagulant
Heparin is a powerful anticoagulant medication used to prevent and treat blood clots in various medical situations. As a critical component in managing thrombotic disorders, understanding its uses, dosage, side effects, and interactions is essential for healthcare providers and patients alike.
The Therapeutic Applications of Heparin
Heparin plays a crucial role in several medical scenarios. Its primary applications include:
- Prevention of deep vein thrombosis (DVT) and pulmonary embolism
- Treatment of acute coronary syndromes
- Anticoagulation during cardiopulmonary bypass and dialysis
- Management of disseminated intravascular coagulation (DIC)
- Prevention of clotting in intravenous lines and catheters
Heparin’s ability to inhibit blood clot formation makes it invaluable in these situations, potentially saving lives and preventing severe complications.
Determining the Correct Heparin Dosage
Heparin dosage is highly individualized and depends on several factors. How is the appropriate dose determined? Healthcare providers consider:
- Patient’s weight
- Medical condition being treated
- Route of administration (intravenous or subcutaneous)
- Results of blood coagulation tests
- Patient’s response to the medication
Typically, heparin is administered as a continuous intravenous infusion or intermittent subcutaneous injections. The dosage is carefully monitored and adjusted based on the patient’s activated partial thromboplastin time (aPTT) or anti-Factor Xa levels to ensure optimal anticoagulation while minimizing the risk of bleeding.
Common Side Effects and Precautions
While heparin is an effective medication, it can cause several side effects. What are the most common adverse reactions patients should be aware of?
- Bleeding (major concern)
- Bruising or pain at the injection site
- Thrombocytopenia (low platelet count)
- Allergic reactions
- Osteoporosis with long-term use
Healthcare providers must carefully monitor patients for signs of excessive bleeding, which can be life-threatening. Additionally, heparin-induced thrombocytopenia (HIT) is a serious complication that requires immediate attention and discontinuation of heparin therapy.
Critical Drug Interactions with Heparin
Heparin interacts with numerous medications, potentially altering its effectiveness or increasing the risk of side effects. Which drugs have major interactions with heparin?
- Other anticoagulants (e.g., warfarin, apixaban)
- Antiplatelet drugs (e.g., clopidogrel, aspirin)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Certain antibiotics
- Thrombolytic agents
These interactions can significantly increase the risk of bleeding or reduce heparin’s anticoagulant effect. Healthcare providers must carefully review a patient’s medication list before initiating heparin therapy and make necessary adjustments to avoid potentially dangerous interactions.
Heparin’s Impact on Specific Medical Conditions
Certain medical conditions can affect how heparin is used or increase the risk of complications. How does heparin affect patients with specific health issues?
- Peptic ulcer disease: Increased risk of gastrointestinal bleeding
- Hypertension: Potential for increased bleeding risk
- Renal dysfunction: May require dose adjustment due to altered drug clearance
- Liver disease: Can affect heparin metabolism and increase bleeding risk
- Recent surgery or trauma: Higher risk of bleeding complications
Healthcare providers must carefully assess a patient’s medical history and current condition before prescribing heparin, adjusting the treatment plan as necessary to ensure safety and efficacy.
Monitoring Heparin Therapy: Ensuring Safety and Efficacy
Proper monitoring is crucial for successful heparin therapy. What parameters are typically assessed during treatment?
- Activated Partial Thromboplastin Time (aPTT)
- Anti-Factor Xa levels
- Platelet count
- Signs of bleeding or thrombosis
- Liver and kidney function tests
Regular monitoring allows healthcare providers to adjust the heparin dose as needed, ensuring that patients maintain therapeutic anticoagulation levels while minimizing the risk of complications. The frequency of monitoring may vary depending on the clinical situation and individual patient factors.
Special Considerations for Heparin Use in Pregnancy and Breastfeeding
Heparin use during pregnancy and breastfeeding requires careful consideration. How does heparin affect pregnant and nursing women?
- Pregnancy: Heparin does not cross the placenta, making it the preferred anticoagulant for pregnant women when indicated
- Risk of osteoporosis with long-term use during pregnancy
- Potential for increased bleeding risk during delivery
- Breastfeeding: Heparin is considered safe as it does not pass into breast milk in significant amounts
Healthcare providers must weigh the benefits of heparin therapy against potential risks for pregnant and breastfeeding women, closely monitoring both mother and baby throughout treatment.
Heparin Alternatives and Emerging Therapies
While heparin remains a cornerstone of anticoagulation therapy, several alternatives have emerged in recent years. What are some of the newer anticoagulant options available?
- Low molecular weight heparins (e.g., enoxaparin)
- Direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and dabigatran
- Fondaparinux, a synthetic pentasaccharide
- Bivalirudin, a direct thrombin inhibitor
These alternatives may offer advantages in certain clinical scenarios, such as easier administration or reduced monitoring requirements. However, the choice of anticoagulant depends on various factors, including the specific medical condition, patient characteristics, and potential drug interactions.
Managing Heparin Overdose and Reversal
In cases of heparin overdose or when rapid reversal of anticoagulation is necessary, healthcare providers have specific strategies. How is heparin overdose managed?
- Administration of protamine sulfate, which neutralizes heparin’s effects
- Careful monitoring of coagulation parameters
- Supportive care for any bleeding complications
- Consideration of additional blood products if severe bleeding occurs
The ability to reverse heparin’s effects quickly is a significant advantage in emergency situations, allowing healthcare providers to manage potentially life-threatening bleeding complications effectively.
Heparin-Induced Thrombocytopenia: A Serious Complication
Heparin-induced thrombocytopenia (HIT) is a rare but potentially severe complication of heparin therapy. What should patients and healthcare providers know about HIT?
- Typically occurs 5-10 days after starting heparin therapy
- Characterized by a significant drop in platelet count
- Can paradoxically increase the risk of thrombosis
- Requires immediate discontinuation of heparin and transition to alternative anticoagulants
- May necessitate long-term anticoagulation even after initial resolution
Early recognition and appropriate management of HIT are crucial to prevent potentially life-threatening complications. Healthcare providers must maintain a high index of suspicion and monitor platelet counts regularly in patients receiving heparin therapy.
Advances in Heparin Formulations and Administration
Ongoing research continues to improve heparin therapy and develop new formulations. What recent advancements have been made in heparin administration?
- Development of synthetic heparin analogues with potentially reduced side effects
- Exploration of oral heparin formulations to improve patient convenience
- Investigation of heparin-coated medical devices to prevent thrombosis
- Refinement of dosing protocols to optimize safety and efficacy
- Integration of pharmacogenomics to personalize heparin therapy
These advancements aim to enhance the safety, efficacy, and ease of use of heparin therapy, potentially expanding its applications and improving patient outcomes.
Economic Considerations in Heparin Therapy
The cost of heparin therapy can vary significantly depending on various factors. What economic considerations should be taken into account when prescribing heparin?
- Comparison of costs between unfractionated heparin and low molecular weight heparins
- Expenses associated with monitoring and dose adjustments
- Potential cost savings from preventing thrombotic complications
- Insurance coverage and patient out-of-pocket expenses
- Long-term economic impact of potential side effects or complications
Healthcare providers and patients must consider these economic factors alongside clinical considerations to ensure optimal and cost-effective anticoagulation therapy.
Patient Education: Key to Successful Heparin Therapy
Proper patient education is crucial for the safe and effective use of heparin. What information should be provided to patients receiving heparin therapy?
- Importance of adherence to the prescribed dosing regimen
- Signs and symptoms of bleeding to watch for and report
- Potential drug and food interactions to avoid
- Proper technique for self-administration of subcutaneous injections
- Importance of regular monitoring and follow-up appointments
Empowering patients with knowledge about their heparin therapy can improve compliance, reduce the risk of complications, and enhance overall treatment outcomes.
Future Directions in Anticoagulation Research
The field of anticoagulation continues to evolve, with ongoing research aimed at improving existing therapies and developing novel approaches. What are some potential future directions in anticoagulation research?
- Development of more selective anticoagulants with reduced bleeding risk
- Exploration of combination therapies to enhance efficacy and safety
- Investigation of anticoagulants with reversible effects for better control
- Personalized anticoagulation strategies based on genetic and clinical factors
- Integration of artificial intelligence in dosing and monitoring protocols
These research directions hold promise for further improving the management of thrombotic disorders and expanding the therapeutic options available to patients and healthcare providers.
In conclusion, heparin remains a critical component of anticoagulation therapy, with wide-ranging applications in various medical scenarios. Its effectiveness in preventing and treating blood clots is balanced by the need for careful monitoring and management of potential side effects and interactions. As research continues to advance our understanding of anticoagulation, heparin therapy will likely evolve, offering improved safety, efficacy, and convenience for patients requiring anticoagulation.
Heparin Interactions Checker – Drugs.com
Save
There are 224 drugs known to interact with
heparin, along with
7 disease interactions, and 1 alcohol/food interaction.
Of the total drug interactions,
58 are major, 143 are moderate, and 23 are minor.
Does heparin interact with my other drugs?
Enter other medications to view a detailed report.
- View all 224 medications that may interact with heparin
- View heparin alcohol/food interactions (1)
- View heparin disease interactions (7)
Most frequently checked interactions
View interaction reports for heparin and the medicines listed below.
- Major
- Moderate
- Minor
- Unknown
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Cardizem (diltiazem)
- Colace (docusate)
- Combivent (albuterol / ipratropium)
- Coumadin (warfarin)
- Dilaudid (hydromorphone)
- Eliquis (apixaban)
- Lantus (insulin glargine)
- Lasix (furosemide)
- Lipitor (atorvastatin)
- Lopressor (metoprolol)
- Lovenox (enoxaparin)
- MiraLAX (polyethylene glycol 3350)
- Norco (acetaminophen / hydrocodone)
- Normal Saline Flush (sodium chloride)
- Norvasc (amlodipine)
- Paracetamol (acetaminophen)
- Percocet (acetaminophen / oxycodone)
- Phenergan (promethazine)
- Plavix (clopidogrel)
- Protonix (pantoprazole)
- Rocephin (ceftriaxone)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
Heparin alcohol/food interactions
There is 1 alcohol/food interaction with heparin.
Heparin disease interactions
There are 7 disease interactions with heparin which include:
- peptic ulcer disease
- active bleeding
- hypertension
- prematurity
- renal dysfunction
- thrombocytopenia
- hyperkalemia
Report options
Loading…
QR code containing a link to this page
More about heparin
- heparin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: heparins
- Breastfeeding
- En español
Related treatment guides
- Angina
- Anticoagulation During Pregnancy
- Antiphospholipid Syndrome
- Deep Vein Thrombosis
Drug Interaction Classification
Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
---|---|
Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Unknown | No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
Heparin (Porcine) Injection: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: Shape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL (1 mL) injection cartridge
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL (1 mL) injection cartridge
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
Heparin sodium drug interactions with other drugs (compatibility) | Vidal.
ru
Heparin sodium drug interactions with other drugs (compatibility) | Vidal.ru – a directory of medicines
|
Our website uses cookies to improve your user experience and performance, as well as marketing activities.
By continuing, you agree to the use of cookies.
Ok
Order a drug
💊 Composition of the drug Heparin ✅ Use of the drug Heparin Save Search for analogues Interaction Description of the active ingredients of the preparation Heparin The scientific information provided is general and cannot be used to make decisions. Update date: 2019.12.04 Marketing authorization holder: SYNTHESIS JSC ATX code: B01AB01 (Heparin) Active substance: Rec. WHO registered Dosage form
Release form, packaging and composition |
D59.3 | Hemolytic uremic syndrome |
D65 | Disseminated intravascular coagulation [defibrination syndrome] |
I20.0 | Unstable angina |
I21 | Acute myocardial infarction |
I26 | Pulmonary embolism |
I33.9 | Acute endocarditis, unspecified |
I34.![]() | Mitral (valvular) insufficiency |
I48 | Atrial fibrillation and flutter |
I74 | Arterial embolism and thrombosis |
I80 | Phlebitis and thrombophlebitis |
I82 | Embolism and thrombosis of other veins |
N00 | Acute nephritic syndrome (acute glomerulonephritis) |
N03 | Chronic nephritic syndrome |
N08.5 | Glomerular lesions in systemic connective tissue diseases |
Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
Dosing regimen
The method of administration and dosing regimen of a particular drug depends on its form of release and other factors. The optimal dosage regimen is determined by the doctor. Compliance of the dosage form of a particular drug with indications for use and dosing regimen should be strictly observed.
Individual, depending on the dosage form used, indications, clinical situation and age of the patient.
Side effects
On the part of the blood coagulation system: possible bleeding of the gastrointestinal tract and urinary tract, bleeding at the injection site, in areas subjected to pressure, from surgical wounds, as well as hemorrhages in other organs, hematuria, thrombocytopenia.
From the digestive system: nausea, loss of appetite, vomiting, diarrhea, increased activity of liver transaminases.
Allergic reactions: flushing of the skin, drug fever, urticaria, rhinitis, pruritus and sensation of heat in the soles, bronchospasm, collapse, anaphylactic shock.
On the part of the blood coagulation system: thrombocytopenia (may be severe up to death) with subsequent development of skin necrosis, arterial thrombosis, accompanied by the development of gangrene, myocardial infarction, stroke.
From the musculoskeletal system: with prolonged use – osteoporosis, spontaneous fractures, soft tissue calcification.
Local reactions: irritation, pain, hyperemia, hematoma and ulceration at the injection site.
Other: transient alopecia, hypoaldosteronism.
Contraindications for use
Bleeding, diseases accompanied by impaired blood coagulation, suspected intracranial hemorrhage, cerebral aneurysm, hemorrhagic stroke, dissecting aortic aneurysm, antiphospholipid syndrome, malignant arterial hypertension, subacute bacterial endocarditis, erosive ulcerative lesions of the gastrointestinal tract , severe lesions of the liver parenchyma, cirrhosis of the liver with varicose veins of the esophagus, malignant neoplasms in the liver, shock conditions, recent surgical interventions on the eyes, brain, prostate, liver and biliary tract, condition after spinal cord puncture, menstruation, threatened miscarriage, childbirth (including recent), hypersensitivity to heparin.
Use during pregnancy and lactation
Use during pregnancy is possible only under strict indications, under close medical supervision.
Contraindication: threatened miscarriage, childbirth (including recent).
Can be used during breastfeeding if indicated.
Use for violations of liver function
Contraindications: severe lesions of the liver parenchyma, cirrhosis of the liver with varicose veins of the esophagus, malignant neoplasms in the liver.
Use for impaired renal function
Used when indicated in patients with severe kidney disease.
Use in children
May be used in children if indicated.
Use in elderly patients
Use with caution in elderly patients (over 60 years, especially in women).
Special instructions
Use with caution in patients suffering from polyvalent allergies (including bronchial asthma), arterial hypertension, dental procedures, diabetes mellitus, endocarditis, pericarditis, in the presence of an intrauterine contraceptive, with active tuberculosis, radiation therapy, liver failure, chronic renal failure, in elderly patients (over 60 years, especially women).
IM administration of heparin is not recommended due to the possibility of developing a hematoma, as well as IM administration of other drugs during treatment with heparin.
Use with caution externally for bleeding and conditions of increased bleeding, thrombocytopenia.
During treatment with heparin, monitoring of blood coagulation parameters is necessary.
Only normal saline is used to dilute heparin.
With the development of severe thrombocytopenia (a decrease in the number of platelets by 2 times from the original number or below 100,000 / µl), heparin should be urgently discontinued.
The risk of bleeding can be minimized with careful evaluation of contraindications, regular laboratory monitoring of blood clotting, and adequate dosing.
Drug interactions
The anticoagulant effect of heparin is enhanced by the simultaneous use of anticoagulants, antiplatelet agents and NSAIDs.
Ergot alkaloids, thyroxine, tetracycline, antihistamines, and nicotine reduce the effect of heparin.